Returning to Orlando for 2023!
At the Gaylord Palms
Looking to the Future of Patient-Centered Care
The 2023 Community Oncology Conference is the premier Conference for independent oncology care teams and stakeholders.
The annual Community Oncology Alliance (COA) Conference is where the biggest issues of the day are discussed. The Enhancing Oncology Model. The Inflation Reduction Act. Practice marketing and advocacy. Direct contracting with employers. Overcoming pharmacy benefit manager abuses. All these issues and more are on the agenda at the 2023 Community Oncology Conference.
Join us for a lively discussion of public policy and regulation, successful practice operations and business strategies, and the latest clinical developments on March 23-24, 2023, right outside Orlando!
Returning to Orlando for 2023!
At the Gaylord Palms
Looking to the Future of Patient-Centered Care
The 2023 Community Oncology Conference is the premier Conference for independent oncology care teams and stakeholders.
The annual Community Oncology Alliance (COA) Conference is where the biggest issues of the day are discussed. The Enhancing Oncology Model. The Inflation Reduction Act. Practice marketing and advocacy. Direct contracting with employers. Overcoming pharmacy benefit manager abuses. All these issues and more are on the agenda at the 2023 Community Oncology Conference.
Join us for a lively discussion of public policy and regulation, successful practice operations and business strategies, and the latest clinical developments on March 23-24, 2023, right outside Orlando!
Returning to Orlando for 2023!
At the Gaylord Palms
Looking to the Future of Patient-Centered Care
The 2023 Community Oncology Conference is the premier Conference for independent oncology care teams and stakeholders.
The annual Community Oncology Alliance (COA) Conference is where the biggest issues of the day are discussed. The Enhancing Oncology Model. The Inflation Reduction Act. Practice marketing and advocacy. Direct contracting with employers. Overcoming pharmacy benefit manager abuses. All these issues and more are on the agenda at the 2023 Community Oncology Conference.
Join us for a lively discussion of public policy and regulation, successful practice operations and business strategies, and the latest clinical developments on March 23-24, 2023, right outside Orlando!
An Agenda for the Future
The agenda for the 2023 Community Oncology Conference looks ahead to what’s coming in health care.
HIGHLIGHTS INCLUDE:
Practice perspectives on the Enhancing Oncology Model
Federal and state policies to curb PBM bad behavior
Working directly with employers
Integrative medicine in cancer
Human resources’ keys to practice success
Enhancing equity in clinical research
Assessing 20 years of advances in cancer care
An Agenda for the Future
The agenda for the 2023 Community Oncology Conference looks ahead to what’s coming in health care.
HIGHLIGHTS INCLUDE:
Practice perspectives on the Enhancing Oncology Model
Federal and state policies to curb PBM bad behavior
Working directly with employers
Integrative medicine in cancer
Human resources’ keys to practice success
Enhancing equity in clinical research
Assessing 20 years of advances in cancer care
Meet Our Fantastic Keynote Speaker
Health care, especially cancer care, can be a humorless arena. At this year’s Community Oncology Conference, we’re tapping into your funny bone and your brain!
Our keynote speaker is Will Flanary, MD, aka Dr. Glaucomflecken. Flanary is well-known to his millions of followers on TikTok, Instagram, Twitter, and YouTube as the doc that cuts through the noise of complicated medical issues with laughter. He frequently comments on the absurdities of the health care system, including hospital bureaucracies, dysfunctional pharmacy benefit managers, and the stereotypical colleagues you might find at any clinic.
World Class Faculty & Speakers
The annual Community Oncology Conference continues to be developed by community oncology providers, administrators, staff, and patients to address their needs in the real world.
The 2023 Community Oncology Conference Co-Chairs are:
Stephen “Fred” Divers, MD
Genesis Cancer & Blood Institute & American Oncology Network
Kathy Oubre
Pontchartrain Cancer Center
Debra Patt
MD, PhD, MBA
Texas Oncology &
US Oncology
Alti Rahman MHA/MBA, CSSBB
Oncology Consultants
Stephen Schleicher MD, MBA
Tennessee Oncology
World Class Faculty & Speakers
The annual Community Oncology Conference continues to be developed by community oncology providers, administrators, staff, and patients to address their needs in the real world.
The 2023 Community Oncology Conference Co-Chairs are:
Stephen “Fred” Divers, MD
Genesis Cancer & Blood Institute & American Oncology Network
Kathy Oubre
Pontchartrain Cancer Center
Debra Patt
MD, PhD, MBA
Texas Oncology &
US Oncology
Alti Rahman MHA/MBA, CSSBB
Oncology Consultants
Stephen Schleicher MD, MBA
Tennessee Oncology
Jeffrey Vacirca
MD, FACP
New York Cancer & Blood Specialists & OneOncology
Executive Platinum Exhibitors
AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit www.astrazeneca-us.com and follow the Company on Twitter @AstraZenecaUS.
Follow Us
Cardinal Health
Daiichi-Sankyo
At Daiichi Sankyo, we create essential medicine for longer, better lives. Every day, we strive to put our skills at the service of those most in need. By uniting cutting-edge science and technology with a genuine interest in people, we develop high-quality, life-changing solutions for the patients of today and tomorrow with great care and unwavering dedication. We rely on reason, ingenuity, perseverance and empathy to make bold strides in oncology.
Our success comes from experts in collaboration: our people, scientists, health care providers, advocates – and patients themselves.
Building on a 120-year heritage and a culture of innovation, we’re forging better futures through medicine for people everywhere. Together, we are creating new standards of care—our contribution to the enrichment of quality of life around the world. Please visit www.daiichisankyo.us.
Flatiron Health®
Flatiron Health is a world leader in transforming patients’ real-life experiences into knowledge to help accelerate improvements in cancer care and treatments.
Follow Us
Genentech
For more than 40 years, we’ve been following the science, seeking solutions to unmet medical needs. As a proud member of the Roche Group, we make medicines to treat patients with serious medical conditions.
We are headquartered in South San Francisco, California.
Incyte
Follow Us
McKesson
Follow McKesson
Follow The US Oncology Network
Merck
At Merck, our goal is to translate breakthrough science into innovative oncology medicines to help people with cancer. The potential to bring new hope to people with cancer drives our purpose and our commitment. As part of our focus on cancer, Merck is committed to clinical research with one of the largest development programs in the industry across more than 30 tumor types.
Regeneron
Gold Exhibitors
Adaptive Biotechnologies
Adaptive Biotechnologies is a commercial-stage biotech company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed. Adaptive’s goal is to develop and commercialize immune-driven diagnostics and therapeutics tailored to each individual patient.
Follow Us
BeiGene
BeiGene is a global, commercial-stage biotechnology company focused on discovering, developing, manufacturing, and commercializing innovative medicines to improve treatment outcomes and access for patients worldwide. Our 9,000+ employees around the world are committed to expediting the development of a diverse pipeline of novel therapeutics.
Follow Us
Exact Sciences
A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its product pipeline to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer.
Follow Us
LeanTaaS
LeanTaaS develops software that increases patient access to medical care by optimizing how health systems use expensive, constrained resources like infusion chairs, operating rooms, and inpatient beds. More than 120 health systems and 485 hospitals – including 40% of the top 25 health systems in the country, based on net patient revenue, 80% of all National Comprehensive Cancer Network institutions, and 55% of all National Cancer Institute locations – rely on the company’s iQueue cloud-based platform to increase patient access, decrease wait times, and reduce healthcare delivery costs. LeanTaaS is based in Santa Clara, California, and Charlotte, North Carolina.
Follow Us
OneOncology
OneOncology was founded by community oncologists, for community oncologists, with the mission of improving the lives of everyone living with cancer. Our goal is to enable community oncology practices to remain independent and to improve patient access to care in their communities, all at a lower cost than in the hospital setting. OneOncology supports our platform of community oncology practices through group purchasing, operational optimization, practice growth, and clinical innovation. Our 850 cancer care providers care for approximately 500,000 patients at more than 175 sites of care nationwide.
Organon
Organon is a global healthcare company formed to focus on improving the health of women throughout their lives. Organon has a portfolio of more than 60 medicines and products across a range of therapeutic areas led by the women’s health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines.
Silver Exhibitors
American Regent, Inc.
American Regent, Inc., a Daiichi Sankyo Group company, is a top-10, US-based injectable drug manufacturer. For over 50 years, American Regent has been developing, manufacturing, and supplying quality generic and branded injectables for healthcare providers and for more than 20 years, we have been a leader in IV iron therapy.
Follow Us
Annexus Health
Annexus Health is the leading healthcare technology company that is revolutionizing the patient access journey by delivering innovative solutions, including tech-enabled services, that reduce financial and administrative burdens to improve access, speed, and adherence to critical care.
Follow Us
CTI Biopharma
We are a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. We concentrate our efforts on treatments that target blood-related cancers where there is an unmet medical need. In particular, we are focused on developing and commercializing pacritinib, our product candidate currently in active late-stage development. We are headquartered in Seattle, Washington.
Follow Us
Mirati Therapeutics
Mirati Therapeutics, Inc. is a clinical-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones. Unified for patients, Mirati’s vision is to unlock the science behind the promise of a life beyond cancer.
Follow Us
Servier Pharmaceuticals
Servier Pharmaceuticals is a commercial-stage pharmaceuticals company with a passion for innovation and improving the lives of patients, their families and caregivers. In the United States, Servier Pharmaceuticals is committed to building a robust portfolio, starting with oncology, with future growth driven by innovation in other areas of unmet medical need, leveraging Servier’s global portfolio and seeking acquisitions, licensing deals and partnerships.
With our commercial and scientific expertise, global reach and commitment to clinical excellence, Servier Pharmaceuticals is dedicated to bringing the promise of tomorrow to the patients that we serve.
Follow Us
Unlimited Systems
Unlimited Systems provides a platform for a wide range of specialty healthcare practices seeking measurable increases in staff productivity, cash flow, and revenue with their feature product Unlimited Financials. Unlimited Financials is a full-featured revenue cycle platform with detailed analytics and task-driven workflows from start to finish. Specialty healthcare practices using Unlimited Financials can be confident that they will achieve peak financial performance.
Follow Us
Thank you
AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit www.astrazeneca-us.com and follow the Company on Twitter @AstraZenecaUS.
Follow Us
Canopy
The first Intelligent Care Platform for oncology, Canopy provides practices and life sciences organizations with intelligent solutions for proactive, outcome-based care. Canopy’s comprehensive and EMR-integrated suite of products includes ePRO-based Patient Monitoring (ePROs), Oral Oncolytics solutions, clinical workflow and patient engagement tools, as well as automated billing, reimbursement capture, and advanced analytics.
Follow Us
CardinalHealth
Exact Sciences
A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its product pipeline to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer.
Follow Us
LeanTaaS
LeanTaaS develops software that increases patient access to medical care by optimizing how health systems use expensive, constrained resources like infusion chairs, operating rooms, and inpatient beds. More than 120 health systems and 485 hospitals – including 40% of the top 25 health systems in the country, based on net patient revenue, 80% of all National Comprehensive Cancer Network institutions, and 55% of all National Cancer Institute locations – rely on the company’s iQueue cloud-based platform to increase patient access, decrease wait times, and reduce healthcare delivery costs. LeanTaaS is based in Santa Clara, California, and Charlotte, North Carolina.
Follow Us
Mirati Therapeutics
Mirati Therapeutics, Inc. is a clinical-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones. Unified for patients, Mirati’s vision is to unlock the science behind the promise of a life beyond cancer.
Follow Us
Organon
Organon is a global healthcare company formed to focus on improving the health of women throughout their lives. Organon has a portfolio of more than 60 medicines and products across a range of therapeutic areas led by the women’s health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines.
Stay up to date with all the latest & greatest news about the conference!
Sign up for the Community Oncology Conference newsletter today and never miss out on the newest updates regarding the event.
